A detailed history of E Fund Management Co., Ltd. transactions in Twist Bioscience Corp stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 8,938 shares of TWST stock, worth $404,980. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,938
Previous 6,261 42.76%
Holding current value
$404,980
Previous $308,000 30.84%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$36.72 - $58.88 $98,299 - $157,621
2,677 Added 42.76%
8,938 $403,000
Q2 2024

Aug 12, 2024

SELL
$27.95 - $53.0 $147,408 - $279,522
-5,274 Reduced 45.72%
6,261 $308,000
Q1 2024

May 13, 2024

SELL
$32.28 - $41.5 $24,145 - $31,042
-748 Reduced 6.09%
11,535 $395,000
Q4 2023

Feb 06, 2024

SELL
$15.08 - $38.61 $77,315 - $197,953
-5,127 Reduced 29.45%
12,283 $452,000
Q3 2023

Nov 13, 2023

SELL
$18.62 - $26.57 $90,046 - $128,492
-4,836 Reduced 21.74%
17,410 $353,000
Q2 2023

Aug 11, 2023

SELL
$11.49 - $20.46 $25,599 - $45,584
-2,228 Reduced 9.1%
22,246 $455,000
Q1 2023

May 11, 2023

BUY
$14.6 - $30.9 $105,747 - $223,808
7,243 Added 42.03%
24,474 $369,000
Q4 2022

Feb 14, 2023

BUY
$21.92 - $39.37 $140,594 - $252,519
6,414 Added 59.3%
17,231 $410,000
Q3 2022

Nov 14, 2022

SELL
$33.44 - $56.56 $185,056 - $313,003
-5,534 Reduced 33.85%
10,817 $381,000
Q2 2022

Aug 15, 2022

BUY
$26.2 - $54.0 $267,895 - $552,150
10,225 Added 166.91%
16,351 $572,000
Q1 2022

May 12, 2022

BUY
$38.58 - $83.27 $198,532 - $428,507
5,146 Added 525.1%
6,126 $303,000
Q1 2021

May 12, 2021

BUY
$105.48 - $207.97 $103,370 - $203,810
980 New
980 $121,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.55B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track E Fund Management Co., Ltd. Portfolio

Follow E Fund Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.